5 Best Undervalued UK Stocks To Buy Now

Page 5 of 5

1. Roivant Sciences Ltd. (NASDAQ:ROIV)

Latest Share Price Upside: 81%

Number of Hedge Fund Investors In Q2 2023: 46

Roivant Sciences Ltd. (NASDAQ:ROIV) is developing treatments for cancer and immune system diseases. Its shares are rated Strong Buy on average and analysts have set an average share price target of $16.22.

For their Q2 2023 investments, 46 among the 910 hedge funds tracked by Insider Monkey had held a stake in Roivant Sciences Ltd. (NASDAQ:ROIV). Daniel Gold’s QVT Financial owns the largest stake among these which is worth $1.2 billion and comes via 122 million shares.

Follow Roivant Sciences Ltd.

Disclosure: None. You can also take a look at 14 Best Cyclical Stocks To Invest In and 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.

Follow Insider Monkey on Twitter

Page 5 of 5